On October 17, 2024, the IRS released two key pieces of guidance, Notice 2024-75 and Notice 2024-71, which provideimportant updates for plan sponsors offering certain […]
The IRS has released cost of living adjustments for 2025 under various provisions of the Internal Revenue Code (the Code).Some of these adjustments may affect […]
The Employee Benefits Security Administration (“EBSA”) of the U.S. Department of Labor confirmed in Compliance Assistance Release No. 2024-01 that cybersecurity guidance issued in 2021 […]
On July 17, 2024, Governor Josh Shapiro signed House Bill 1993 (“the Bill”) into law. The Bill seeks to further regulatepharmacy benefit managers (“PBMs”) by, […]
The IRS released final instructions and forms for calendar year 2024 ACA reporting, including Forms 1094-C, 1095-C, 1094-B, and 1095-B. As a reminder, it is […]
For plan years beginning on or after January 1, 2025, employers that took advantage of temporary relief to offer free (or reduced cost) telehealth or […]
The IRS recently announced that the Affordable Care Act (“ACA”) affordability indexed amount under the Employer Shared
Responsibility Payment (“ESRP”) requirements will be 9.02% for plan years that begin in 2025. This is a significant increase from the 2024 percentage amount (8.39%) but remains below the original 9.5% threshold.
Employers are required to notify participants and beneficiaries who are Medicare Part D eligible individuals and the Centers
for Medicare and Medicaid Services (“CMS”) of the creditable or non-creditable status of the group health plan prescription
drug plan(s).
Changes to Medicare Part D Creditable Coverage Determination The Inflation Reduction Act of 2022 (“IRA”) made several changes that will affect the structure of the […]
Change Healthcare Data Breach HIPAA Considerations Earlier this year, Change Healthcare, a large health payment processing company, announced a massive data breach which compromised personal […]
This decision overturns long-standing precedent established in Chevron U.S.A. Inc., v. Natural Resources Defense Council, Inc. (“Chevron”) that required federal courts to defer to an executive agency’s reasonable interpretation of ambiguous statutory provisions the agency administers (often referred to as Chevron deference).
The Departments of Labor, the Treasury, and Health and Human Services (collectively, “the Departments”) recently issued the updated Annual Submission Instructions and User Manual to facilitate the Gag Clause Prohibition Compliance Attestation (“GCPCA”) for 2024.